Planta Med 2014; 80(07): 577-582
DOI: 10.1055/s-0034-1368354
Natural Product Chemistry
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Lipase Inhibition and Antiobesity Effect of Atractylodes lancea

Ping Jiao
1   Unigen USA, Seattle, WA, USA
,
Julie Tseng-Crank
1   Unigen USA, Seattle, WA, USA
,
Brandon Corneliusen
1   Unigen USA, Seattle, WA, USA
,
Mesfin Yimam
1   Unigen USA, Seattle, WA, USA
,
Mandee Hodges
1   Unigen USA, Seattle, WA, USA
,
Mei Hong
1   Unigen USA, Seattle, WA, USA
,
Catherine Maurseth
1   Unigen USA, Seattle, WA, USA
,
Misun Oh
2   Unigen Korea, Cheonam Si, Chungnam, South Korea
,
Hyunjin Kim
2   Unigen Korea, Cheonam Si, Chungnam, South Korea
,
Min Chu
1   Unigen USA, Seattle, WA, USA
2   Unigen Korea, Cheonam Si, Chungnam, South Korea
,
Qi Jia
1   Unigen USA, Seattle, WA, USA
2   Unigen Korea, Cheonam Si, Chungnam, South Korea
› Author Affiliations
Further Information

Publication History

received 17 December 2013
revised 06 March 2014

accepted 10 March 2014

Publication Date:
31 March 2014 (online)

Abstract

The ethanol extract of Atractylodes lancea rhizome displayed significant lipase inhibition with an IC50 value of 9.06 µg/mL in a human pancreatic lipase assay from high-throughput screening. Bioassay-guided isolation led to the identification of one new polyacetylene, syn-(5E,11E)-3-acetoxy-4-O-(3-methylbutanoyl)-1,5,11-tridecatriene-7,9-diyne-3,4-diol (7), along with six known compounds (16). The structure of compound 7 was determined based on the analysis of NMR and MS data. Among these seven lipase inhibitors, the major compound atractylodin (1) showed the highest lipase inhibitory activity (IC50 = 39.12 µM). The antiobesity effect of the ethanol extract of Atractylodes lancea rhizome was evaluated in a high-fat diet-induced obesity mice model at daily dosages of 250 mg/kg and 500 mg/kg body weight for 4 weeks, and treatment with this extract demonstrated a moderate efficacy at the 500 mg/kg dose level.

Supporting Information